featured
Tau PET as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
JAMA Neurol 2021 Aug 01;78(8)961-971, R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, O Strandberg, S Palmqvist, T Olsson, J Jögi, E Stormrud, H Cho, YH Ryu, JY Choi, AL Boxer, ML Gorno-Tempini, BL Miller, D Soleimani-Meigooni, L Iaccarino, R La Joie, S Baker, E Borroni, G Klein, MJ Pontecorvo, MD Devous, WJ Jagust, CH Lyoo, GD Rabinovici, O HanssonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.